Abstract
Background: American Society of Anesthesiologists (ASA; Schaumburg, Illinois) Physical Status (PS) classification is a widely used ordinal scale that captures comorbidity burden but has significant interrater variability. Previous efforts to enhance ASA PS documentation with clinical decision support are limited by inaccurate problem lists, poor user experience, or consideration of select comorbidities. The authors developed and implemented clinical decision support which uses the anesthesia clinicians’ documentation to highlight potential underclassification at time of ASA PS assignment. Methods: Building upon examples from the ASA Committee on Economics and institutional consensus, the authors identified 51 conditions warranting an ASA PS of at least III. This was embedded in clinical decision support and implemented at the authors’ large academic medical center (site 1). The authors compared the percentage of patients assigned an ASA PS III or greater before (May 22, 2023, to May 22, 2024) and after complete implementation (August 14, 2024, to August 14, 2025). A second large midwestern academic medical center served as a contemporaneous external control (site 2). Using a difference in difference analysis, the authors constructed odds ratios for assignment of ASA PS III in all patients and selected subpopulations. Results: The study included 251,944 anesthetics from site 1 and 286,172 from site 2. Baseline characteristics were similar between sites. At site 1, the proportion of patients classified as ASA PS III or higher increased from 52.9 to 61.7% (adjusted odds ratio [aOR], 1.42; 95% CI, 1.38 to 1.45). Site 2 experienced a small absolute increase from 47.2 to 48.4% (aOR, 1.05; 95% CI, 1.03 to 1.07). Among patients at site 1 with 50 conditions addressed by the latter phase of the clinical decision support, the proportion classified as ASA PS III or greater increased from 83.6 to 94.0% (aOR, 3.54; 95% CI, 3.34 to 3.76). Conclusions: Implementation of the authors’ in-line real-time clinical decision support was associated with a significant increase in the percentage of patients with ASA PS III or greater.

This publication has 14 references indexed in Scilit: